These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20507206)

  • 21. Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men.
    Ghosn J; Viard JP; Katlama C; de Almeida M; Tubiana R; Letourneur F; Aaron L; Goujard C; Salmon D; Leruez-Ville M; Rouzioux C; Chaix ML
    AIDS; 2004 Feb; 18(3):447-57. PubMed ID: 15090797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profile of HIV type 1 infection and genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV type 1-infected individuals in Hai Phong, Viet Nam.
    Ishizaki A; Cuong NH; Thuc PV; Trung NV; Saijoh K; Kageyama S; Ishigaki K; Tanuma J; Oka S; Ichimura H
    AIDS Res Hum Retroviruses; 2009 Feb; 25(2):175-82. PubMed ID: 19239356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.
    Verhofstede C; Van Wanzeele F; Van Der Gucht B; Pelgrom J; Vandekerckhove L; Plum J; Vogelaers D
    J Med Virol; 2007 Sep; 79(9):1254-60. PubMed ID: 17607772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication.
    Crowe SM; Sonza S
    J Leukoc Biol; 2000 Sep; 68(3):345-50. PubMed ID: 10985250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/ml.
    Kupfer B; Matz B; Däumer MP; Roden F; Rockstroh JK; Qurishi N; Spengler U; Kaiser R
    J Med Virol; 2007 Oct; 79(10):1440-5. PubMed ID: 17705170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of drug resistance-associated and background mutations in human immunodeficiency virus type 1 CRF01_AE protease and reverse transcriptase derived from drug treatment-naive patients residing in central Thailand.
    Auwanit W; Isarangkura-Na-Ayuthaya P; Kasornpikul D; Ikuta K; Sawanpanyalert P; Kameoka M
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):625-31. PubMed ID: 19500016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients.
    Descamps D; Lambert-Niclot S; Marcelin AG; Peytavin G; Roquebert B; Katlama C; Yeni P; Felices M; Calvez V; Brun-Vézinet F
    J Antimicrob Chemother; 2009 Mar; 63(3):585-92. PubMed ID: 19147519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.
    Kieffer TL; Kwon P; Nettles RE; Han Y; Ray SC; Siliciano RF
    J Virol; 2005 Feb; 79(3):1975-80. PubMed ID: 15650227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission.
    Delaugerre C; Morand-Joubert L; Chaix ML; Picard O; Marcelin AG; Schneider V; Krivine A; Compagnucci A; Katlama C; Girard PM; Calvez V
    Antivir Ther; 2004 Jun; 9(3):415-21. PubMed ID: 15259904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.
    Ghosn J; Pellegrin I; Goujard C; Deveau C; Viard JP; Galimand J; Harzic M; Tamalet C; Meyer L; Rouzioux C; Chaix ML;
    AIDS; 2006 Jan; 20(2):159-70. PubMed ID: 16511408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART.
    Monno L; Punzi G; Scarabaggio T; Saracino A; Brindicci G; Fiore JR; Iambrenghi OC; Di Stefano M; Pastore G; Angarano G
    J Med Virol; 2003 May; 70(1):1-9. PubMed ID: 12629636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART.
    Delobel P; Sandres-Sauné K; Cazabat M; L'Faqihi FE; Aquilina C; Obadia M; Pasquier C; Marchou B; Massip P; Izopet J
    AIDS; 2005 Nov; 19(16):1739-50. PubMed ID: 16227781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
    Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
    J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First observation of HIV type 1 drug resistance mutations in Algeria.
    Bouzeghoub S; Jauvin V; Pinson P; Schrive MH; Jeannot AC; Amrane A; Masquelier B; Belabbes el H; Fleury HJ
    AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1467-73. PubMed ID: 19032068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.
    Richard N; Juntilla M; Abraha A; Demers K; Paxinos E; Galovich J; Petropoulos C; Whalen CC; Kyeyune F; Atwine D; Kityo C; Mugyenyi P; Arts EJ
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):355-64. PubMed ID: 15157354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir.
    Canducci F; Marinozzi MC; Sampaolo M; Boeri E; Spagnuolo V; Gianotti N; Castagna A; Paolucci S; Baldanti F; Lazzarin A; Clementi M
    J Antimicrob Chemother; 2010 Mar; 65(3):425-33. PubMed ID: 20056687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 protease and reverse transcriptase derived from drug-treated Indonesian patients.
    Khairunisa SQ; Kotaki T; Witaningrum AM; Yunifiar M MQ; Sukartiningrum SD; Nasronudin ; Kameoka M
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):255-9. PubMed ID: 25348045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study).
    Pellegrin I; Wittkop L; Joubert LM; Neau D; Bollens D; Bonarek M; Girard PM; Fleury H; Winters B; Saux MC; Pellegrin JL; Thiébaut R; Breilh D;
    Antivir Ther; 2008; 13(2):271-9. PubMed ID: 18505178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
    Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.